ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Ophthalmology

Top Ophthalmology Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
J. HENRY M.D.

Ophthalmology

6,133

$319K

766
671 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 57%

$52
Average prescription price

Avg: $58

DAVID BAKER MD

Ophthalmology

6,019

$161K

1107
1002 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 57%

$27
Average prescription price

Avg: $58

SCOTT CLAYCOMB MD

Ophthalmology

3,819

$219K

697
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 57%

$57
Average prescription price

Avg: $58

RANDY ENNEN M.D.

Ophthalmology

3,625

$180K

834
694 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 57%

$50
Average prescription price

Avg: $58

CLAIRE PRICE M.D.

Ophthalmology

3,554

$247K

706
646 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 57%

$70
Average prescription price

Avg: $58

THOMAS STANK M.D.

Ophthalmology

3,390

$176K

775
688 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 57%

$52
Average prescription price

Avg: $58

GLEN BRYANT MD

Ophthalmology

3,320

$114K

751
607 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 57%

$34
Average prescription price

Avg: $58

CHARLES HOF M.D.

Ophthalmology

3,305

$207K

707
635 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 57%

$63
Average prescription price

Avg: $58

KENNETH KILGORE M.D.

Ophthalmology

3,295

$194K

815
742 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 57%

$59
Average prescription price

Avg: $58

JOE HESTER MD

Ophthalmology

3,157

$216K

580
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 57%

$69
Average prescription price

Avg: $58

MICHAEL MCFARLAND MD

Ophthalmology

3,091

$225K

969
822 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

76%
prescriptions for brand name drugs

Avg: 57%

$73
Average prescription price

Avg: $58

RANDALL COLE M.D.

Ophthalmology

2,996

$145K

693
622 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

21%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 57%

$48
Average prescription price

Avg: $58

JAMES BRAUN MD

Ophthalmology

2,952

$146K

624
580 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 57%

$50
Average prescription price

Avg: $58

HAROLD PEARSON MD

Ophthalmology

2,942

$339K

510
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

91%
prescriptions for brand name drugs

Avg: 57%

$115
Average prescription price

Avg: $58

LYDIA LANE M.D.

Ophthalmology

2,894

$160K

438
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 57%

$55
Average prescription price

Avg: $58

IVORY KINSLOW MD

Ophthalmology

2,650

$68K

562
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

26%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 57%

$26
Average prescription price

Avg: $58

PAUL MISISCHIA D.O.

Ophthalmology

2,623

$183K

716
609 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 57%

$70
Average prescription price

Avg: $58

INCI IRAK DERSU MD

Ophthalmology

2,585

$176K

319
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 57%

$68
Average prescription price

Avg: $58

MATTHEW MARGOLIS D.O.

Ophthalmology

2,534

$167K

713
604 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 57%

$66
Average prescription price

Avg: $58

KENNETH JONES M.D.

Ophthalmology

2,475

$148K

510
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 57%

$60
Average prescription price

Avg: $58

CHRISTOPHER GREER DO

Ophthalmology

2,407

$165K

489
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 57%

$68
Average prescription price

Avg: $58

RICHARD MCDOUGAL MD

Ophthalmology

2,306

$63.2K

324
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 57%

$27
Average prescription price

Avg: $58

ROBERT KNOX M.D.

Ophthalmology

2,262

$151K

565
525 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 57%

$67
Average prescription price

Avg: $58

BLAKE GEREN M.D.

Ophthalmology

2,074

$139K

413
351 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 57%

$67
Average prescription price

Avg: $58

FRED GEORGE M.D.

Ophthalmology

2,065

$86.1K

323
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 57%

$42
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank